ERDOMED 225 mg gru por 1x20 bags

Product name: ERDOMED 225 mg gru por 1x20 bags

ERDOMED 225 mg granules for oral suspension 20 sachets

• promotes expectoration in respiratory diseases
• 1 sachet contains 225 mg of erdosteine
• for adults and adolescents aged 12 and over
• pleasant orange flavour

When to take ERDOMED 225 mg?

ERDOMED 225 mg is a mucolytic, i.e. a medicine that reduces the viscosity of mucus (thins mucus) and makes it easier to cough up.

It is used to treat acute upper and lower respiratory tract infections associated with increased mucus production, such as:

• rhinitis (rhinitis),
• sinusitis (sinusitis),
• inflammation of the larynx (laryngitis) and pharynx (pharyngitis),
• bronchitis (bronchitis).
• It is also used on the advice of a doctor to treat certain chronic respiratory diseases, e.g. frequently recurring bronchitis (chronic bronchitis), to worsen the symptoms of bronchial asthma and chronic obstructive pulmonary disease (COPD), in smokers to prevent chronic bronchitis and to prevent frequently recurring infections (e.g. during the winter).

How to take ERDOMED 225 mg?

→Dosing←

• Adults and children over 12 years take 1 sachet 2-3 times a day.
• The effect of the treatment will be felt after 3 days, the average length of treatment to achieve the full effect is 7 days. If you do not feel better or feel worse within 7 days, contact your doctor.
  In chronic diseases, the drug can be used under the supervision of a doctor even for a longer period of time.
• Do not take the medicine shortly before bedtime.
• Do not take the medicine at the same time as antitussives (cough suppressants) because of the risk of large amounts of mucus accumulating in the airways.

Sufficient fluid intake is required during treatment.

→Method of use←

Dissolve the contents of the sachet in approximately 120 ml (half the volume of a normal glass) of lukewarm water or tea, stir and drink immediately. The drug can be taken independently of food.

Notice

• The drug should not be administered during pregnancy and while breastfeeding.
• The drug is contraindicated in children with a body weight of less than 15 kg.
• The drug is contraindicated in severe renal insufficiency (creatinine clearance < 25 ml/min).
• The drug should not be used in liver disorders or abnormalities.
• The oral dose of erdosteine in patients with mild hepatic impairment is limited to a maximum of 300 mg daily.
• The drug is contraindicated in patients with severe hepatic impairment.
• The drug should be used with caution in patients with gastric or duodenal ulcer.
• The drug contains aspartame and sucrose.
• Due to the content of sodium benzoate, the drug can cause allergic reactions (with a possible delay).
• Further specific warnings are given in the PIL (Part 2).

Read the patient package leaflet carefully before taking the medicine.

The drug is used to reduce the mucous-like, possibly purulent exudate of the respiratory tract mucosa and to facilitate expectoration when:

• acute and chronic bronchitis, bronchodilation and bronchial asthma with increased mucus secretion
• acute and chronic inflammation of the upper respiratory tract, such as rhinitis, sinusitis, laryngitis and pharyngitis.

The drug is also used to prevent the aggravation of bronchial bronchial disease, especially in:

• disorders of the respiratory system accompanied by emphysema (excessive air in the lungs) and increased secretion
• chronic bronchitis
• emphysema of the lungs (excessive air content in the lungs).

The drug may also be used to prevent complications after surgery, such as pneumonia or non-ventilation of part of the lung. More at adc.sk

Dosage and dosage schedules

Adults, elderly patients and children with a body weight over 30 kg (over 12 years): 1 sachet 2-3 times a day

Patients with severe liver failure should take half the dose.

The therapeutic effect is evident after 3 days of treatment; the average length of treatment to achieve the full effect is 7 days.
In chronic diseases, the drug can be used under the supervision of a doctor even for a longer period of time.

Method of use

The contents of the bag are dissolved in a glass of water and drunk. The drug can be taken independently of food.

Notice

The drug should not be administered during pregnancy and in the period of breastfeeding.
The drug is contraindicated in children with a body weight of less than 15 kg.
The drug is contraindicated in severe renal insufficiency (creatinine clearance < 25 ml/min).
The drug should not be used in liver disorders or abnormalities.
The drug contains aspartame and sucrose.
Due to the content of sodium benzoate, the drug can cause allergic reactions (with a possible delay).
Further special warnings are given in the SPC (section 4.4).

erdosteine